iShares Nasdaq Profile

111.22
USD 1.78  1.58%
16%
7%

iShares Nasdaq Summary

iShares Nasdaq Biotechnology ETF [IBB] is traded in USA and was established 2001-02-05. The fund is classified under Health category within iShares family. iShares Nasdaq Biotechnology ETF currently have 9.79 B in assets under management (AUM). , while the total return for the last 3 years was 6.68%.
Check iShares Nasdaq Probability Of Bankruptcy

Geographic Allocation (%)

Sector Allocation (%)

iShares Nasdaq Biote Currency Exposure (%)

 % of ETF 
      Currency 

Top Etf Constituents

iShares Nasdaq Target Price Odds Analysis

Odds Below 111.22HorizonTargetOdds Above 111.22
10.62%30 days 111.22 89.23%
Based on normal probability distribution, the odds of iShares Nasdaq to move above current price in 30 days from now is about 89.23% (This iShares Nasdaq Biotechnology ETF probability density function shows the probability of iShares Nasdaq Etf to fall within a particular range of prices over 30 days) .

iShares Nasdaq Biote Top Holders

iShares Nasdaq Biote Risk Profiles

iShares Nasdaq Biote Technical Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of seventeen. iShares Nasdaq Biote Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe iShares Nasdaq price patterns. View also all equity analysis or get more info about inverse tangent over price movement math transform indicator.

iShares Nasdaq Key Fundamentals

iShares Nasdaq Against Markets

iShares Nasdaq Current Ratings

iShares Nasdaq Biotechnology ETF 30 Days Performance Scores

Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
2 
Equity ratings for iShares Nasdaq Biotechnology ETF are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of companies listed on NASDAQ that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq, Inc. iShares Nasdaq is traded on NASDAQ General Markets in USA. more
NameiShares Nasdaq Biotechnology ETF
ChairmanGeorge ParkerView All
Macroaxis Advice
InstrumentUSA Etf View All
RegionNorth America
Investment IssuerBlackRock
ExchangeNASDAQ General Markets
Etf FamilyiShares
Fund CategorySector
Portfolio ConcentrationHealth Care
BenchmarkDOW
Phone800 474 2737
CurrencyUSD - US Dollar
IssuerBlackRock
DescriptioniShares Nasdaq Biotechnology ETF
Inception Date2001-02-05
BenchmarkNASDAQ Biotechnology TR USD
Entity TypeRegulated Investment Company
Asset Under Management9.16 Billion
Average Trading Valume1.86 Million
Asset TypeEquity
CategorySector
FocusHealth Care
Market ConcentrationDeveloped Markets
RegionNorth America
AdministratorState Street Bank and Trust Company
AdvisorBlackRock Fund Advisors
CustodianState Street Bank and Trust Company
DistributorBlackRock Investments, LLC
Portfolio ManagerDiane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason
Transfer AgentState Street Bank and Trust Company
Fiscal Year EndMarch 31
ExchangeThe NASDAQ Stock Market LLC
Number of Constituents193
Market MakerVirtu Financial
Total Expense0.47
Management Fee0.47
Nav Price121.95
Last Bear Mkt0.00%
Two Hundred Day Average112.53
Ytd14.40%
Average Daily Volume In Three Month1.97M
Trailing Annual Dividend Rate0.64
Fifty Two Week Low100.22
Last Bull Mkt0.00%
Trailing Annual Dividend Yield0.59%
Average Daily Volume Last 10 Day2.53M
Fifty Two Week High122.97
Please also check Risk vs Return Analysis. Please also try Cryptocurrency Arbitrage module to find pairs of digital assets on multiple exchanges that are traded at a risk free arbitrage.
Search macroaxis.com